NCT00309608 - Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes | Biotech Hunter

Enrollment

333

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Linagliptin

Linagliptin medium dose tablet once daily

DRUG

Linagliptin

Linagliptin high dose tablet once daily

DRUG

Linagliptin

Linagliptin low dose tablet once daily

DRUG

Placebo

Placebo tablets once daily

DRUG

Glimepiride

Glimepiride tablets once daily

Trial Locations (48)

Unknown

1218.6.3302A Boehringer Ingelheim Investigational Site, Joué Les Tours

1218.6.3303A Boehringer Ingelheim Investigational Site, Joué Les Tours

1218.6.3304A Boehringer Ingelheim Investigational Site, Joué-lès-Tours

1218.6.3305A Euraxi Pharma, Joué-lès-Tours

1218.6.3301A Boehringer Ingelheim Investigational Site, Paris

1218.6.49007 Boehringer Ingelheim Investigational Site, Aschaffenburg

1218.6.49013 Boehringer Ingelheim Investigational Site, Bosenheim

1218.6.49008 Boehringer Ingelheim Investigational Site, Dresden

1218.6.49009 Boehringer Ingelheim Investigational Site, Düsseldorf

1218.6.49014 Boehringer Ingelheim Investigational Site, Heidelberg

1218.6.49012 Boehringer Ingelheim Investigational Site, Immenstadt im Allgäu

1218.6.49001 Boehringer Ingelheim Investigational Site, Mainz

1218.6.49005 Boehringer Ingelheim Investigational Site, Neuwied

1218.6.49017 Boehringer Ingelheim Investigational Site, Offenbach A. M.

1218.6.49002 Boehringer Ingelheim Investigational Site, Saarbrücken

1218.6.49010 Boehringer Ingelheim Investigational Site, Saint Ingbert/Oberwürzbach

1218.6.49011 Boehringer Ingelheim Investigational Site, Sinsheim

1218.6.49015 Boehringer Ingelheim Investigational Site, Sulzbach-Rosenberg

1218.6.49016 Boehringer Ingelheim Investigational Site, Wangen

1218.6.49003 Boehringer Ingelheim Investigational Site, Würzburg

1218.6.42103 Boehringer Ingelheim Investigational Site, Banská Bystrica

1218.6.42104 Boehringer Ingelheim Investigational Site, Bratislava

1218.6.42105 Boehringer Ingelheim Investigational Site, Bratislava

1218.6.42101 Boehringer Ingelheim Investigational Site, Nové Mesto nad Váhom

1218.6.46003 Boehringer Ingelheim Investigational Site, Gothenburg

1218.6.46001 Boehringer Ingelheim Investigational Site, Malmo

1218.6.46002 Boehringer Ingelheim Investigational Site, Uddevalla

1218.6.46004 Boehringer Ingelheim Investigational Site, Uppsala

1218.6.38002 Boehringer Ingelheim Investigational Site, Dnyepropetrovsk

1218.6.38001 Boehringer Ingelheim Investigational Site, Kiev

1218.6.38003 Boehringer Ingelheim Investigational Site, Kiev

1218.6.38005 Boehringer Ingelheim Investigational Site, Kiev

1218.6.44012 Boehringer Ingelheim Investigational Site, Ashford

1218.6.44004 Boehringer Ingelheim Investigational Site, Baillieston, Glasgow

1218.6.44002 Boehringer Ingelheim Investigational Site, Bath

1218.6.44003 Boehringer Ingelheim Investigational Site, Birmingham

1218.6.44013 Boehringer Ingelheim Investigational Site, Camberley

1218.6.44016 Boehringer Ingelheim Investigational Site, Chorley

1218.6.44007 Boehringer Ingelheim Investigational Site, Dundee

1218.6.44006 Boehringer Ingelheim Investigational Site, Exeter

1218.6.44005 Boehringer Ingelheim Investigational Site, Gillingham

1218.6.44015 Boehringer Ingelheim Investigational Site, Glasgow

1218.6.44008 Boehringer Ingelheim Investigational Site, Guildford

1218.6.44017 Boehringer Ingelheim Investigational Site, Liverpool

1218.6.44001 Boehringer Ingelheim Investigational Site, London

1218.6.44018 Boehringer Ingelheim Investigational Site, Manchester

1218.6.44009 Boehringer Ingelheim Investigational Site, Newcastle upon Tyne

1218.6.44019 Boehringer Ingelheim Investigational Site, Reading